Enterotoxigenic Escherichia coli or Vibrio cholerae 569B (Inaba) grown in the presence of the antibiotic lincomycin, an inhibitor of protein synthesis, produced elevated levels of heat-labile enterotoxin or choleragen, respectively, as assayed by both vascular permeability factor and capacity to elicit fluid accumulation in rabbit ileal loops. This induction of enterotoxin did not reflect either a coupling of lincomycin resistance with increased enterotoxigenicity or an effect of lincomycin on cellular release of enterotoxin, since spontaneously isolated lincomycin-resistant mutants ofboth E. coli and V. cholerae still required lincomycin for induction, and large increases in E. coli permeability factor activity were found intracellularly as well as extracellularly. After the period of exponential growth, E. coli became refractory to induction by lincomycin, although most of the induced enterotoxin activity appeared only after this period. No increase in copy number of the enterotoxin plasmid in E. coli 711 (P307) was found in induced cells by analysis of deoxyribonucleic acid reassociation kinetics. These and other data suggest that synthesis of enterotoxin, or at least its accumulation, is normally limited by cellular factors whose synthesis is preferentially inhibited by lincomycin. A possible connection between this phenomenon and lincomycinassociated diarrhea is considered.
The antibiotic lincomycin is a potent inhibitor of protein synthesis in gram-positive bacteria at concentrations on the order of 1 ,tg/ml. It also inhibits protein synthesis in Escherichia coli, but only at concentrations about 100-fold higher. The basis of this difference in sensitivity is unknown, but it appears to be reflected in cell-free protein synthesis as well as in intact cells (3) . In vitro, lincomycin blocks the peptidyltransferase function of 50S ribosomal subunits, but the mechanism of inhibition in whole cells is not yet established (11) .
We find that lincomycin acts as an inducer of enterotoxin activity in both enterotoxigenic E. coli and Vibrio cholerae. This phenomenon may provide a useful probe for analyzing the regulation of synthesis, about which little is presently known, of these enterotoxins, and it suggests that the E. coli and V. cholerae enterotoxins, which cross-react immunologically and are similar in their modes of action (13) , may also be similar with regard to the mechanisms which regulate their production. This finding may also have relevance for the understanding of lincomycin-associated diarrhea, a severe and frequent response to oral lincomycin therapy (9) .
(A preliminary report of this and related work was presented by M. Levner, R. Rappaport, and B. A. Rubin at the 1976 Annual Meeting of the American Society for Microbiology, 2-7 May, Atlantic City, N.J.)
MATERIALS AND METHODS
Bacterial strains. Enterotoxigenic E. coli strains used included H197 and H10407, isolated from human subjects with cholera-like diarrhea and provided by R. Rappaport, and 711 (P307) and 711 (P155), K-12 strains carrying enterotoxin-specifying (ent) plasmids derived from E. coli strains of porcine origin and obtained from S. Falkow, who also provided the isogenic non-enterotoxigenic ent-strain 711. Vibrio cholerae 569B (Inaba) was also provided by R. Rappaport. Lincomycin-resistant (Linr) mutants are spontaneous isolates resistant to at least 300 ug (E. coli) or 60 ug (V. cholerae) of lincomycin per ml under our growth conditions, obtained by serial transfer of liquid cultures at increasing concentrations of lincomycin, followed by purification of resistant clones. The Linr phenotype is stable in the absence of the drug.
Media and growth conditions for enterotoxin production. Overnight cultures grown in 2% (wt/ vol) peptone and 0.5% (wt/vol) NaCl at 37°C without aeration were diluted 1:1,000 in 40 ml of yeast extract-supplemented Casamino Acids-salts medium (synyeast) (6) , at times containing lincomycin (Lincocin, Upjohn) at various concentrations, and were rotated vigorously in 500-ml Erlenmeyer flasks at 3700. In our hands, heat-labile E. coli enterotoxin, assayed as described below, appears to be released into the growth medium primarily during cell lysis, since its release approximately parallels that of (-galactosidase (M. Levner and R. Rappaport, unpublished data), and we routinely assayed extracellular enterotoxin activity after a 48-h incubation. This procedure was also used for V. cholerae.
Enterotoxin assays. (i) Rabbit skin test. Portions of bacterial cultures were cleared by centrifugation at room temperature, and supernatants were filtered through 0.45-jum (E. coli) or 0.22-Am (V. cholerae) membrane filters (Millipore Corp.) prior to assay for vascular permeability factor (PF) by the rabbit skin test, performed essentially as described by Evans et al. (5) . PF activity, which forE. coli is a measure of heat-labile enterotoxin under these assay conditions (5) , is expressed as the concentration (ml-') of 4-mm bluing doses. Each figure is the average of data obtained with two rabbits. The ratio of lincomycin-induced PF activity to uninduced activity varied from 10-to 80-fold for E. coli H197 Lin! and from 4-to 330-fold for V. cholerae 569B Linr in at least five repetitions of these experiments, in each of which induced and noninduced cultures were grown and assayed in parallel.
(ii) Beal loop assay. Ligated rabbit ileal loops were injected with 1.0-ml portions of enterotoxin preparations at appropriate dilutions, and accumulation of fluid was measured 18 h later as described by Rappaport et al. (12) .
Estimation of relative plasmid DNA concentrations by reassociation kinetics. E. coli 711 (P307), which carries an enterotoxin-specifying plasmid (ent) and no other plasmids (7, 14) (10), consisted essentially of treatment of lysozyme-ethylenediaminetetraacetic acid-disrupted cells with 1% sodium dodecyl sulfate at 60°C for 10 min, followed by the addition of NaClO4 to 1.0 M and extraction with chloroform-isoamyl alcohol (24:1) (vol/vol). After dialysis overnight at 40C against 0.42 M NaCl, digestion was carried out with 50 Ag of boiled pancreatic ribonuclease (Calbiochem) per ml at 3700 for 30 min, followed by further extraction and dialysis with chloroform-isoamyl alcohol and 0.42 M NaCl, respectively.
DNA reassociation reactions were carried out at 750C in 0.42 M NaCl, using 3H-labeled ent DNA in trace amounts, such that its renaturation was negligible in the incubation periods used, in the absence of added DNA. Unlabeled total cellular DNA was added to concentrations at least 750 times that of3H-labeled ent DNA. All D,.NAs were sonically treated for 5 min with a Branson Sonifier at 150 W in an ice bath before denaturation by boiling for 10 min. The extent of reassociation of homologous singlestranded DNA molecules was determined by sensitivity of the labeled probe DNA to single-strandspecific S1 nuclease. Portions of DNA mixtures after various periods of incubation at 750C were diluted at least 30-fold into ice-cold S1 buffer (60 mM sodium acetate, 50 mM NaCl, 1 mM ZnCl,, pH 4.5) containing 20 .tg of denatured, sonically treated calf thymus DNA per ml, and stored at -20°C. All samples were then assayed simultaneously. S1 nuclease (Miles Laboratories, Inc.) was added to a concentration of 1,000 to 2,000 units/ml, and samples were incubated for 10 min at 370C. An equal volume of ice-cold 10% trichloroacetic acid was then added; after-at least 20 min on ice the samples were collected on Whatman GF/C filters, which were then dried and counted in Liquiflor-toluene scintillation fluid. Under these assay conditions, no detectable digestion of sonically treated native 3H-labeled total cellular E. coli 711 (P307) DNA occurred. A fraction of all 3H-labeled ent DNA preparations, which varied from 8 to 13%, remained resistant to S1 nuclease after boiling. The high degree of specificity in the assay is attested to by the data in Fig. 3 , where it is shown that no detectable reassociation occurred in a mixture of total cellular DNA from E. coli 711, which lacks the ent plasmid, with trace amounts of 3H-labeled ent DNA.
Reassociation data were plotted in terms of 1/f.,, the reciprocal of the fraction of labeled ent DNA remaining single stranded, as a function of time of incubation at 750C (t), and f. was corrected for the fraction of ent DNA remaining S1 resistant at t = 0 (8 to 13%) and S1 sensitive at apparent completion of the reaction (about 50%). Since, as mentioned above, native DNA was essentially completely S1 resistant, the reason for this high value off. at the end of reassociation is not clear. Since 1/f. = 1 + KCot for an ideal second-order reaction and a given unique DNA sequence (2) , where K is a constant, the slope of the reassociation curves was taken to be proportional to the concentration ofent DNA (Co) in VOL. 15, 1977 on October 26, 2017 by guest http://iai.asm.org/ Downloaded from the unlabeled total cellular DNA, since the concentration of labeled ent DNA was negligible.
RESULTS
Induction of increased E. coli enterotoxin production by lincomycin is shown in Table 1 . In experiment la, growth of E. coli H197 in medium containing 30 ,ug of lincomycin per ml resulted in at least a sevenfold increase in extracellular PF activity. At 100 ,ug of lincomycin per ml growth ofE. coli H197 was severely inhibited, but cultures eventually attained a high cell density, suggesting that selection for lincomycin-resistant cells might also select for cells with increased enterotoxigenicity. However, isolations of spontaneous Line mutants, which are stably resistant to at least 300 gg of lincomycin per ml, indicated (as shown for one such mutant in Table 1 , experiment lb) that this was not the case. Without the drug, no significant increase in PF activity was found, whereas in 100 to 500 jig of lincomycin per ml, at least 25-fold enhancement was observed. Of 11 such mutants independently isolated from strain H197, 10 showed at least a fivefold increase in PF production when grown with 250 ug of lincomycin per ml. Three other enterotoxigenic E. coli strains were also examined for lincomycin induction, and all showed increased PF activity when grown in the presence of 50 ,ug of lincomycin per ml (Table 1 , experiment 2).
V. cholera enterotoxin (choleragen) is also susceptible to lincomycin induction. A sponta- neous Linr mutant of V. cholerae 569B (Inaba) was isolated, and a 60-fold increase in extracellular PF activity was observed in 50 ,ug of lincomycin per ml (Table 1, experiment 3). As with E. coli, this induction required drug in the growth medium.
The capacity of E. coli H197 Linr to be induced by lincomycin declined with time after inoculation of cultures (Fig. 1) . In this experiment, addition of lincomycin at 7 h (midlog phase) reduced the ultimate yield of PF activity by about 75% relative to that obtained by addition of drug at inoculation, and by 14 h (postlog phase) the cells were completely refractory to induction. Although we occasionally found maximal induction to occur when lincomycin was added as late as 7 h, a refractory state was invariably attained by about 14 h. The Linr phenotype is stable during growth in the absence of lincomycin; since little or no PF activity appeared prior to 7 h either intra-or extracellularly (data not shown) and most of the induced activity appeared after 12 h (see Fig. 2 and below), these data suggest that the amount of enterotoxin activity ultimately produced was limited by lincomycin-sensitive events occurring early in the growth of cultures. The data in Fig. 1 The samples were then cleared by centrifugation, filtered through 0.45-pm membrane filters (Millipore) and assayed for PF activity as described in Materials and Methods. Symbols: * -, E. coli H197; 0----0 E. coli H197 Lin'; 0-O, E. coli H197 LinT with lincomycin (250 uglml) added at 0 h. activity of lincomycin itself in the PF assay, since no induction was seen when drug was added at any time after 14 h.
The possibility that lincomycin acted solely by altering cellular release of enterotoxin was examined by determining intracellular PF activity released by sonic disruption. As shown in Fig. 2, at 12, 18 , and 24 h after inoculation, strain H197 Linr grown with lincomycin contained significantly higher levels of PF activity than either H197 Linr or the parent strain H197 grown without drug. Without lincomycin, intracellular PF activity declined after 12 h, whereas H197 Linr grown with the drug continued to accumulate activity for at least 24 h. At 24 h the induced cells contained several hundred times as much activity as the uninduced cells.
That lincomycin-induced increases in PF activity did in fact reflect increases in enterotoxin was substantiated by concomitant increases in capacity to elicit fluid accumulation in rabbit intestine (13) for both E. coli and V. cholera. Enterotoxin from cultures grown with and without lincomycin was assayed both by skin test and in ligated ileal loops, and increased PF activity was invariably associated with increased stimulation of intestinal fluid accumulation ( Table 2) .
The synthesis of enterotoxin is specified in many strains of E. coli by a plasmid (ent) (15, 16) . Using one such strain (E. coli 711 [P307]), we found no significant increase in the amount of ent DNA per cell during lincomycin induction of enterotoxin by analysis (see Materials and Methods) of the kinetics of reassociation of purified 3H-labeled ent DNA with total DNA from induced or uninduced stationary-phase Fig. 1 and 2 Fig. 1 ), and that early addition of lincomycin is only necessary because enough is retained intracellularly in this way to maintain the induced state through several division cycles. (As shown in Fig. 2 , induced cells continue to produce increased amounts of PF activity until at least 24 h after inoculation.) This seems unlikely since E. coli H197 Linr retains its diminished (relative to H197) but significant sensitivity to lincomycin, as measured by incorporation of radioactive amino acids into protein, in stationary phase (data not shown).
Other workers have shown that E. coli enterotoxin is probably a periplasmic protein (6) . Preliminary data from our laboratory indicate that the periplasmic enzyme streptomycin adenylate synthase, specified by a plasmid conferring resistance to streptomycin (1), can also be induced by lincomycin, and it may be that such compartmentalization is a factor in determining susceptibility to lincomycin induction. (It is not known whether choleragen is also periplasmic.) Although recent work indicates that the synthesis of choleragen involves only chromosomal genes (17) , in contrast to the E. coli ent plasmid, the fact that both E. coli and V. cholerae enterotoxins are induced by lincomycin suggests that their synthesis may involve regulation by similar mechanisms.
These results also pose the question of whether induction of enterotoxin by lincomycin can occur in the human intestine. The occurrence of diarrhea accompanying lincomycin therapy (9) , for example, suggests a possible role of enterotoxigenic bacteria in this circumstance, although it should be noted that this symptom apparently occurs only after the cessation of administration of the drug (9) .
